{"id":510403,"title":"Rozlytrek - Notice of Compliance with Conditions - Qualifying Notice - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T07:12:56.598000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/rozlytrek-qualifying-notice.html","snippet":"Rozlytrek - Notice of Compliance with Conditions - Qualifying Notice Therapeutic Product Directorate Holland Cross, Tower \"B\" 6th Floor, 1600 Scott Street Address Locator #3106B OTTAWA, Ontario K1A 0K9 Dossier ID: E221250 Dear [Employee name removed] Hoffmann-La Roche Limited…","rawSnapshotUrl":"/api/snapshots/raw/510403","browseUrl":"https://replay.healtharchive.ca/job-6/20260216071256/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/rozlytrek-qualifying-notice.html#ha_snapshot=510403","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}